ホーム › クローン病 › オハイオ › Cleveland
Cleveland、OHにおけるクローン病の臨床試験
Clevelandとその周辺地域（約30マイル以内）の拠点で、クローン病に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
被験者募集中第3相
- Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · 22マイル先
Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
被験者募集中健康なボランティア歓迎
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · 17マイル先
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
被験者募集中第4相
- Great Lakes Gastroenterology Research, LLC, Mentor · 22マイル先
Non-nutritive Sweeteners in Inflammatory Bowel Disease
被験者募集中健康なボランティア歓迎
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · 17マイル先
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- Great Lakes Gastroenterology Research, LLC, Mentor · 22マイル先
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Great Lakes Gastroenterology Research, LLC, Mentor · 22マイル先
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Cleveland Clinic - Cleveland /ID# 256453, Cleveland
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
被験者募集中第4相
- Great Lakes Gastroenterology Research, LLC, Mentor · 22マイル先
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Great Lakes Gastroenterology Research, LLC, Mentor · 22マイル先
Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD
被験者募集中
- Cleveland Clinic, Cleveland
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- UH Cleveland Medical Center /ID# 262188, Cleveland
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
被験者募集中第3相
- University Children's Clinic, Cleveland
- Cleveland Clinic, Cleveland
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
被験者募集中第4相
- UH/Rainbow Babies and Children's Hospital, Cleveland
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
被験者募集中第3相
- University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Precise Infliximab Exposure and Pharmacodynamic Control
被験者募集中第2/3相
- Cleveland Clinic Children's Hospital, Cleveland
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
被験者募集中第3相
- University Hospitals Cleveland Medical Center, Cleveland
Treatment of Moderate to Severe Refractory Crohn's Disease
被験者募集中第1/2相
- Cleveland Clinic, Cleveland
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
被験者募集中観察研究
- Cleveland Clinic Foundation, Cleveland
他の都市におけるクローン病の試験
- New York City, NY35件の研究
- Boston, MA19件の研究
- Miami, FL19件の研究
- St. Louis, MO19件の研究
- Tyler, TX17件の研究
- Houston, TX17件の研究
- Orlando, FL17件の研究
- Atlanta, GA17件の研究
- San Antonio, TX15件の研究
- San Diego, CA15件の研究
- Los Angeles, CA15件の研究
- Colorado Springs, CO13件の研究
Clevelandにおける他の研究
- 非小細胞肺癌43件の研究
- がん（全種類）36件の研究
- 乳がん35件の研究
- 前立腺がん34件の研究
- 心不全33件の研究
- 卵巣がん30件の研究
- 転移性癌30件の研究
- 肺がん26件の研究
- 大腸癌24件の研究
- 心血管疾患22件の研究
- 子宮内膜がん20件の研究
- 急性骨髄性白血病20件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。